Yayın:
Use of linezolid in children

Basit Görünüm
dc.contributor.buuauthorÇelebi, Solmaz
dc.contributor.buuauthorÇELEBİ, SOLMAZ
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.date.accessioned2024-10-08T12:05:26Z
dc.date.available2024-10-08T12:05:26Z
dc.date.issued2007-06-01
dc.description.abstractLinezolid is an oxazolidinone antibacterial agent that acts by inhibiting the initiation of bacterial protein synthesis. Linezolid has a wide spectrum of activity against grampositive organisms including vancomycin resistant Enterococcus faecium, vancomycin resistant Enterococcus faecalis, methicillin resistant staphylococci and penicillin resistant pneumococci. Linezolid has a good bioavability orally and could be switched from parenteral to oral therapy while treating serious infections. Linezolid is well tolerated inchildren.
dc.identifier.endpage69
dc.identifier.issn1307-1068
dc.identifier.issue2
dc.identifier.startpage68
dc.identifier.urihttps://hdl.handle.net/11452/46085
dc.identifier.volume1
dc.identifier.wos000422166900004
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherAves Yayincilik, Ibrahim Kara
dc.relation.journalJournal Of Pediatric Infection
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectLinezolid
dc.subjectGrampositive infection
dc.subjectChildren
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectPediatrics
dc.titleUse of linezolid in children
dc.typeReview
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
local.indexed.atWOS
relation.isAuthorOfPublication28076e30-7802-4de2-ae05-028643d56968
relation.isAuthorOfPublication.latestForDiscovery28076e30-7802-4de2-ae05-028643d56968

Dosyalar

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications